Judit Gellen
Hematology & Oncology · South Portland, MENPI 1407817406
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (35.5%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 38 manufacturers reported payments, led by Athenex Pharmaceutical Division, LLC at 35.5% of the total. Reporting peaked in 2020 at $4,572 and has fallen 96.4% since, to $167 in 2023.
Across 221 payments — averaging $49.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Athenex Pharmaceutical Division, LLC$4K
- Bristol Myers Squibb$2K
- Novartis$2K
- E.r. Squibb & Sons, L.L.C.$612
- Johnson & Johnson$427
- Pfizer$424
- plus $2K from 32 others
What the payments were for
- Consulting fees$1,64015%
- Speaking & faculty fees$3,85035%
- Travel & lodging$520%
- Food & beverage$3,22830%
- Education$5735%
- Other$1,51514%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Athenex Pharmaceutical Division, LLC | 3 | $3,850 |
| Bristol Myers Squibb | 10 | $1,836 |
| Novartis | 24 | $1,634 |
| E.r. Squibb & Sons, L.L.C. | 42 | $612 |
| Johnson & Johnson(2 entities) | 22 | $427 |
| Pfizer | 24 | $424 |
| Amgen | 14 | $286 |
| Astellas Pharma US Inc | 7 | $254 |
| Seagen Inc. | 4 | $149 |
| Merck | 9 | $148 |
| AstraZeneca(2 entities) | 8 | $128 |
| AVEO Pharmaceuticals, Inc. | 2 | $114 |
| Comsort, Inc | 1 | $100 |
| Array Biopharma Inc | 6 | $93 |
| Eisai Inc. | 4 | $75 |
| EMD Serono, Inc. | 4 | $72 |
| Pharmacyclics LLC, An Abbvie Company | 4 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $60 |
| Bayer | 3 | $58 |
| Beigene USA, Inc. | 3 | $53 |
| AbbVie | 3 | $44 |
| Myovant Sciences Inc. | 2 | $41 |
| Rigel Pharmaceuticals, Inc. | 2 | $40 |
| Lilly USA, LLC | 2 | $32 |
| Daiichi Sankyo Inc. | 2 | $30 |
| Sanofi | 1 | $21 |
| Incyte Corporation | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Tactile Systems Technology Inc | 1 | $20 |
| Kyowa Kirin, Inc. | 1 | $19 |
| Epizyme, Inc. | 1 | $19 |
| GSK | 1 | $17 |
| Stemline Therapeutics Inc. | 1 | $17 |
| Exelixis Inc. | 1 | $16 |
| Puma Biotechnology, Inc. | 1 | $16 |
| Morphosys, US Inc. | 1 | $16 |
| Agios Pharmaceuticals, Inc. | 1 | $16 |
| Genentech USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Oral Paclitaxel$3,850
- Encequidar$3,850
- CAR-T$1,661
- KEYTRUDA$100
How this compares
$10,858 in reported general payments places this provider in the 75th percentile of 60 hematology & oncology providers in Maine.
Other hematology & oncology in South Portland
- Jason MoranSouth Portland$18K
- Jason AdlerSouth Portland$2K
- Pamela EganSouth Portland$471
- Michael AusterSouth Portland$258
- Sarah KetchumSouth Portland$60
- Xiao HuSouth Portland$30
- Matthew DuganWestbrook$577K
- John WintersWestbrook$341K
- Helen RyanKennebunk$83K
- Eleni NackosWestbrook$79K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.